368a.T
368A.T is a Japanese medical equipment and supplies company that generates revenue primarily through the sale of healthcare products and services.
Business. 368A.T is a Japanese medical equipment and supplies company that generates revenue primarily through the sale of healthcare products and services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
368A.T is a Japanese medical equipment and supplies company that generates revenue primarily through the sale of healthcare products and services.
368A.T maintains a strong liquidity position with a current ratio of 11.99, indicating a high ability to meet short-term obligations. The company's cash and equivalents amount to 13.414 billion JPY, which is a significant portion of its total assets of 21.996 billion JPY. The debt-to-equity ratio is 0.0, suggesting that the company is not leveraged and relies primarily on equity financing.
In terms of profitability, 368A.T demonstrates a return on equity (ROE) of 28.79% and a return on assets (ROA) of 26.84%, both of which are well above the typical thresholds for the healthcare equipment and supplies industry. The company's operating income of 5.858 billion JPY and net income of 5.904 billion JPY reflect strong operational performance.
The company's revenue is concentrated in the healthcare services and equipment segment, with no disclosed geographic diversification. Given the lack of segment or geographic breakdown in the provided data, it is unclear if the company has significant exposure to any particular region or product line.
Looking at the growth trajectory, the company's revenue in the latest period was 10.947 billion JPY, while the mean analyst estimate for the next period is 11.6 billion JPY. This suggests a potential growth of approximately 6.0% in the next fiscal year. The company's free cash flow of 5.855 billion JPY indicates that it has substantial cash available for reinvestment or distribution to shareholders.
The risk assessment for 368A.T indicates a low level of liquidity and dilution risk. There are no immediate filing-based liquidity or dilution flags, and the company's capital structure is not expected to change significantly in the near term. The dilution potential is low, and no adjustments have been applied to the valuation metrics.
Recent events, as reflected in the financial data, show that the company has outperformed analyst estimates in terms of EPS, with an actual EPS of 197.82 JPY compared to a mean estimate of 100.00 JPY. This indicates strong earnings performance and positive investor sentiment.
- 368A.T has a strong liquidity position with a current ratio of 11.99 and no debt, indicating a high ability to meet short-term obligations.
- The company's profitability is robust, with a return on equity of 28.79% and a return on assets of 26.84%.
- The company's revenue is concentrated in the healthcare services and equipment segment, with no disclosed geographic diversification.
- The company's revenue is expected to grow by approximately 6.0% in the next fiscal year, based on analyst estimates.
- The risk assessment indicates a low level of liquidity and dilution risk, with no immediate filing-based flags.
- **margin_outlook_rationale**: The company's strong operating income and net income suggest that margins are likely to remain stable or improve in the near term.
- **rd_outlook_rationale**: No specific information is provided regarding R&D spending, but the company's strong profitability may indicate ongoing investment in innovation.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 100,00 |
| Revenue | —no estimate | —no estimate | 11,6B JPY |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 368A.T Market data — financials · 2026-05-26
- Kitazato Corp Market data — analyst estimates · 2026-05-26